Key facts
- Notable investors include Yinxinggu Capital, Hangzhou Oufang Venture Capital Management, Hangzhou Biotest Biotech.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Qingshi Yongjun
- ·The full record, as it builds
Funding rounds
No funding rounds for Qingshi Yongjun are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Qingshi Yongjun
Developer of neuromodulation-focused medical systems intended for therapeutic and clinical intervention purposes.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Qingshi Yongjun doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Qingshi Yongjun shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Qingshi Yongjun in its N-PORT filings yet. We sweep new filings monthly.